These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8126857)

  • 1. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats.
    Allaire E; Guettier C; Bruneval P; Plissonnier D; Michel JB
    J Vasc Surg; 1994 Mar; 19(3):446-56. PubMed ID: 8126857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic arterial rejection and immunogenicity of the extracellular matrix in iso-, allo- and xenograft in rats].
    Allaire E; Michel JB
    Chirurgie; 1993-1994; 119(10):634-41. PubMed ID: 7729181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoluminal smooth muscle cell seeding limits intimal hyperplasia.
    Gomes D; Louedec L; Plissonnier D; Dauge MC; Henin D; Osborne-Pellegrin M; Michel JB
    J Vasc Surg; 2001 Oct; 34(4):707-15. PubMed ID: 11668328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glutaraldehyde on experimental arterial iso- and allografts in rats.
    Dumont CE; Plissonnier D; Guettier C; Michel JB
    J Surg Res; 1993 Jan; 54(1):61-9. PubMed ID: 8429640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology and immunohistochemistry of rat aortic grafts.
    Rossmann P; Lácha J; Lodererová A
    Folia Microbiol (Praha); 1999; 44(3):339-53. PubMed ID: 10664891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of chronic rejection of aortic allografts by dietary glycine.
    Yin M; Rusyn I; Schoonhoven R; Graves LM; Rusyn EV; Li X; Li F; Cox AD; Harding TW; Bunzendahl H; Swenberg JA; Thurman RG
    Transplantation; 2000 Mar; 69(5):773-80. PubMed ID: 10755525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in the rat.
    Allaire E; Mandet C; Bruneval P; Bensenane S; Becquemin JP; Michel JB
    Transplantation; 1996 Sep; 62(6):794-803. PubMed ID: 8824480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats.
    Plissonnier D; Levy BI; Salzmann JL; Nochy D; Watelet J; Michel JB
    Arterioscler Thromb; 1991; 11(6):1690-9. PubMed ID: 1931870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenicity of the extracellular matrix in arterial xenografts.
    Allaire E; Bruneval P; Mandet C; Becquemin JP; Michel JB
    Surgery; 1997 Jul; 122(1):73-81. PubMed ID: 9225918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycerol-preserved arterial allografts evaluated in the infrarenal rat aorta.
    Fahner PJ; Idu MM; van Gulik TM; van Wijk B; van der Wal AC; Legemate DA
    Eur Surg Res; 2009; 42(2):78-86. PubMed ID: 19052464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment of aortic allografts.
    Schmitz-Rixen T; Megerman J; Colvin RB; Williams AM; Abbott WM
    J Vasc Surg; 1988 Jan; 7(1):82-92. PubMed ID: 3257275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
    Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
    Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy inhibits experimental allograft rejection. A novel approach for the development of vascular bioprostheses.
    LaMuraglia GM; Adili F; Schmitz-Rixen T; Michaud NA; Flotte TJ
    Circulation; 1995 Oct; 92(7):1919-26. PubMed ID: 7671376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation.
    Allaire E; Muscatelli-Groux B; Mandet C; Guinault AM; Bruneval P; Desgranges P; Clowes A; Méllière D; Becquemin JP
    J Vasc Surg; 2002 Nov; 36(5):1018-26. PubMed ID: 12422114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential immunological targeting of chronic experimental arterial allograft.
    Plissonnier D; Nochy D; Poncet P; Mandet C; Hinglais N; Bariety J; Michel JB
    Transplantation; 1995 Sep; 60(5):414-24. PubMed ID: 7676487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased production of cytokines and growth factors by aortic allografts: A possible explanation for myointimal hyperplasia formation.
    Sterpetti AV; Cucina A; Randone B; Guglielmi MB; Fragale A; Cavallaro A
    Eur Surg Res; 1999; 31(4):297-304. PubMed ID: 10449988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.
    Ouyang J; Xu D; Zhang X; Qi S; Ma A; Jiang W; Chida N; Sudo Y; Tamura K; Daloze P; Chen H
    Transplantation; 2005 May; 79(10):1386-92. PubMed ID: 15912108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection.
    Chow LH; Huh S; Jiang J; Zhong R; Pickering JG
    Circulation; 1996 Dec; 94(12):3079-82. PubMed ID: 8989111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method for long-lasting preservation of arterial grafts.
    Gewartowska M; Olszewski WL; Buyanowskaya O; Frontczak-Baniewicz M
    J Surg Res; 2016 Jan; 200(1):374-86. PubMed ID: 26323366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.